TF and cancer: A number of cancer/stromal cells are known to highly express tissue factor and microvesicles contain active-TF, having an impact in cancer progression and increasing the risk of venous thromboembolism (Owens and Mackman, 2011; van den Berg et al., 2012; Unruh and Horbinski, 2020).